ITUB20153076A1 - Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. - Google Patents

Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento.

Info

Publication number
ITUB20153076A1
ITUB20153076A1 ITUB2015A003076A ITUB20153076A ITUB20153076A1 IT UB20153076 A1 ITUB20153076 A1 IT UB20153076A1 IT UB2015A003076 A ITUB2015A003076 A IT UB2015A003076A IT UB20153076 A ITUB20153076 A IT UB20153076A IT UB20153076 A1 ITUB20153076 A1 IT UB20153076A1
Authority
IT
Italy
Prior art keywords
active compounds
pharmaceutically active
therapeutic treatment
movement disorders
disorders
Prior art date
Application number
ITUB2015A003076A
Other languages
English (en)
Inventor
Gualtiero Giovando
Samuele Giovando
Original Assignee
Sp Walker S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sp Walker S R L filed Critical Sp Walker S R L
Priority to ITUB2015A003076A priority Critical patent/ITUB20153076A1/it
Priority to ITUB2015A005006A priority patent/ITUB20155006A1/it
Publication of ITUB20153076A1 publication Critical patent/ITUB20153076A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
ITUB2015A003076A 2015-08-11 2015-08-11 Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. ITUB20153076A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITUB2015A003076A ITUB20153076A1 (it) 2015-08-11 2015-08-11 Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento.
ITUB2015A005006A ITUB20155006A1 (it) 2015-08-11 2015-10-29 Composti farmaceuticamente attivi per l’impiego nel trattamento terapeutico di disturbi del movimento.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A003076A ITUB20153076A1 (it) 2015-08-11 2015-08-11 Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento.

Publications (1)

Publication Number Publication Date
ITUB20153076A1 true ITUB20153076A1 (it) 2017-02-11

Family

ID=54843906

Family Applications (2)

Application Number Title Priority Date Filing Date
ITUB2015A003076A ITUB20153076A1 (it) 2015-08-11 2015-08-11 Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento.
ITUB2015A005006A ITUB20155006A1 (it) 2015-08-11 2015-10-29 Composti farmaceuticamente attivi per l’impiego nel trattamento terapeutico di disturbi del movimento.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ITUB2015A005006A ITUB20155006A1 (it) 2015-08-11 2015-10-29 Composti farmaceuticamente attivi per l’impiego nel trattamento terapeutico di disturbi del movimento.

Country Status (1)

Country Link
IT (2) ITUB20153076A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101475483A (zh) * 2009-01-21 2009-07-08 北京师范大学 β-(3,4-二羟基苯基)-α-羟基丙酸酯类化合物的医药用途
US20100137194A1 (en) * 2007-04-16 2010-06-03 The Regents Of The University Of Michigan Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
CN102552233A (zh) * 2011-12-26 2012-07-11 暨南大学 3,4-二羟基苯甲酸甲酯在制备防治神经退行性疾病药物中的应用
CN103054847A (zh) * 2013-01-04 2013-04-24 中国药科大学 丹酚酸b作为儿茶酚-o-甲基转移酶抑制剂在帕金森病治疗中的应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137194A1 (en) * 2007-04-16 2010-06-03 The Regents Of The University Of Michigan Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
CN101475483A (zh) * 2009-01-21 2009-07-08 北京师范大学 β-(3,4-二羟基苯基)-α-羟基丙酸酯类化合物的医药用途
CN102552233A (zh) * 2011-12-26 2012-07-11 暨南大学 3,4-二羟基苯甲酸甲酯在制备防治神经退行性疾病药物中的应用
CN103054847A (zh) * 2013-01-04 2013-04-24 中国药科大学 丹酚酸b作为儿茶酚-o-甲基转移酶抑制剂在帕金森病治疗中的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200966, 2009 Derwent World Patents Index; AN 2009-L64565, XP002755880 *
DATABASE WPI Week 201260, 2012 Derwent World Patents Index; AN 2012-L70720, XP002755881 *
DATABASE WPI Week 201369, 2013 Derwent World Patents Index; AN 2013-P86337, XP002755882 *
DELPHINE LAMORAL-THEYS ET AL: "Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 18, no. 11, 1 June 2010 (2010-06-01), pages 3823 - 3833, XP055089839, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2010.04.047 *

Also Published As

Publication number Publication date
ITUB20155006A1 (it) 2017-04-29

Similar Documents

Publication Publication Date Title
HK1251257A1 (zh) 用於醫治疾病的外泌體的用途
IL260383B (en) Low dose medication
IL258471A (en) 11,13-modified saxitoxins for the treatment of pain
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
DK3258938T3 (da) Phenothiazinanaloger som mitokondrie terapeutiske midler
IL247969B (en) A medicinal component for use in the treatment of infections
DK3307277T3 (da) Enkeltstrengede oligonukleotider til anvendelse i medicinsk behandling af hudlidelser
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
HK1251476A1 (zh) 用於治療癌症的氨基硫羥酸酯化合物或其藥學上可接受的鹽
IL248428A0 (en) Use of 3,1-propanedisulfonic acid or pharmaceutically acceptable saline to treat sarcoidosis
ITUB20169928A1 (it) Formulazioni farmaceutiche per il trattamento del diabete
CL2018002930A1 (es) (+)-azasetron para uso en el tratamiento de desórdenes de oído.
IL259381B (en) Miravegron for the treatment of retinal diseases
ITUB20153076A1 (it) Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento.
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
DK3270923T3 (da) Terapeutisk middel til frontallapsdysfunktion
ITUA20163037A1 (it) Formulazioni per uso nel trattamento o prevenzione di disturbi urologici
AU2016902139A0 (en) New Therapeutic Treatment Combination
ITUB20160672A1 (it) Composizione farmaceutica per il trattamento della disidrosi
ITUB20155450A1 (it) Composizione per il trattamento delle dermatiti.
ITUB20152369A1 (it) Dispositivo per il trattamento di lesioni vascolari complesse.
GB201506944D0 (en) Therapeutic treatment